Add BrightSurf on Google Email

Research brief: Association between diabetes medication and less severe cases of COVID-19

A study published in PLOS ONE found that adults with type 2 diabetes taking metformin had a 45% lower risk of needing a breathing machine or dying from COVID-19 compared to those not taking the medication. The research team analyzed data from a large database and suggested metformin may be an effective treatment option for reducing COV...

SourceUniversity of Minnesota Medical School·JournalPLOS ONE·TypeData/statistical analysis·DateNov 17, 2022

People with diabetes may benefit more from a pancreas transplant than other treatments

A new study published in the Journal of Clinical Endocrinology & Metabolism reveals that pancreas transplantation can provide up to 90% of recipients with diabetes freedom from insulin therapy and glucose monitoring. Despite high success rates, transplant numbers have declined due to lack of consensus criteria, education, and resource ...

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateNov 15, 2022

Promise of better treatment for diabetes in Greenland after discovery of widespread genetic variant

A novel HNF1A gene variant has been found to cause monogenic diabetes, affecting almost seven percent of all cases in Greenland. This discovery may pave the way for precision treatment using tablet therapy with sulphonylurea, offering a simpler and cheaper alternative to insulin.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalThe Lancet Regional Health - Europe·TypeExperimental study·DateNov 15, 2022

Digital and group-based lifestyle counselling to prevent type 2 diabetes shows real-world effectiveness in Finnish health care

A one-year lifestyle intervention with a digital app and group counselling improved diet quality, reduced abdominal obesity and insulin resistance among 2907 Finnish adults at risk of type 2 diabetes. The study suggests that commitment to lifestyle counselling supports positive changes.

SourceUniversity of Eastern Finland·JournalThe Lancet Regional Health - Europe·DateOct 27, 2022

At risk for diabetes? Cut the carbs, says new study

Researchers at Tulane University have discovered that following a low-carbohydrate diet can lead to reduced hemoglobin A1c levels and improved fasting glucose levels among individuals with unmedicated diabetes and prediabetes. The study suggests that a low-carb diet may be a useful approach for preventing and treating Type 2 diabetes.

SourceTulane University·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateOct 26, 2022

Effects of low-carbohydrate dietary intervention on A1C

A 6-month randomized clinical trial found that a low-carbohydrate diet intervention resulted in larger reductions in hemoglobin A1c (HbA1c) levels compared to usual diet among adults with elevated untreated HbA1c. The study suggests that this dietary approach may be useful for preventing and treating type 2 diabetes.

SourceJAMA Network·JournalJAMA Network Open·DateOct 26, 2022

Switching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signaling

Helmholtz Munich researchers identified a novel strategy to alter glucagon receptor signaling by changing its intracellular localization. This approach offers therapeutic potential for treating type 2 diabetes by uncoupling glucose and lipid metabolism-related effects.

Drug discovery method identifies naturally occurring metabolite that converts ‘bad’ fat to ‘good’ fat

A team of scientists at Scripps Research and Calibr discovered a naturally occurring metabolite called myristoylglycine that can convert white fat cells into brown fat cells, potentially treating obesity and related diseases. The breakthrough uses a novel drug discovery method to identify endogenous metabolites with therapeutic potential.

SourceScripps Research Institute·JournalMetabolites·DateOct 13, 2022

Research brief: Two popular diabetes drugs outperformed others in large clinical trial

A large clinical trial found that insulin glargine and liraglutide were superior to other diabetes drugs in controlling blood sugars. The study, published in the New England Journal of Medicine, compared four common medications used to treat type 2 diabetes when added to metformin.

SourceUniversity of Minnesota Medical School·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 7, 2022

Do attitudes and behaviors in response to stress impact the health of older people with diabetes?

A study published in the Journal of the American Geriatrics Society found that individuals with type 2 diabetes who exhibit psychological resilience experience fewer hospitalizations, better physical functioning, and a lower likelihood of becoming frail. Psychological resilience also appears to mitigate aging-related concerns.

SourceWiley·JournalJournal of the American Geriatrics Society·DateOct 5, 2022

Lipids in blood predict nerve damage risk among patients with type 2 diabetes

A study at Michigan Medicine found multiple lipid biomarkers linked to diabetic neuropathy in patients with type 2 diabetes. High scores for neuropathy were associated with changes in lipids reflecting impaired energy metabolism, suggesting a potential target for testing and managing the condition.

SourceMichigan Medicine - University of Michigan·JournalAnnals of Clinical and Translational Neurology·TypeObservational study·DateSep 29, 2022

Diabetes self-care reached by 32% who built trust with community health workers, study finds

A study found that building trust with community health workers (promotores) can lead to long-term self-care in type 2 diabetes patients. 32.4% of participants achieved 'self-care generativity,' while 40.5% progressed to 'stabilization.' The model, called Nosotros, could be replicated to improve chronic disease management.

SourceUniversity of Texas Health Science Center at San Antonio·JournalThe Annals of Family Medicine·TypeObservational study·DateSep 26, 2022

BU study: Monthly caps on out-of-pocket costs would provide financial relief to privately insured patients

A new study found that placing a monthly cap on out-of-pocket costs for commercially insured patients could lower their highest monthly healthcare bills by 50-60%. A $500 monthly limit would affect about 25% of enrollees and reduce in-network OOP costs over a year by 46%, while a $250 limit would show a 51% reduction.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateSep 22, 2022

New study explains link between diabetes and UTIs

Research at Karolinska Institutet shows that people with diabetes have lower levels of psoriasin, a key peptide that weakens the bladder's protective barrier function. This increases the risk of urinary tract infections. Oestrogen therapy may help regulate the immune response to UTIs in patients with diabetes.

SourceKarolinska Institutet·JournalNature Communications·TypeExperimental study·DateSep 20, 2022

Diabetes: When circadian lipid rhythms go wrong

A study by the University of Geneva team shows that disrupted circadian clocks lead to a rigidity in the membrane of pancreatic endocrine cells, affecting their function. The researchers also found that lipid profiles oscillate more during the day than previously thought, particularly in phospholipids and sphingolipids.

SourceUniversité de Genève·JournalPLOS Biology·TypeNews article·DateSep 19, 2022

Exercise and education: Diabetes prevention work helps local Latino children, families

A study led by Arizona State University Professor Gabriel Shaibi found that a community-based program combining education and exercise significantly improves the health of Latino children at risk for diabetes. The program, which included 117 families from around the Valley, provided culturally focused lessons on healthy eating and phys...

SourceArizona State University·JournalJAMA·TypeRandomized controlled/clinical trial·DateSep 12, 2022